<DOC>
	<DOCNO>NCT02552212</DOCNO>
	<brief_summary>Patients active Axial Spondyloarthritis without x-ray evidence Ankylosing Spondylitis sign inflammation randomly assign receive certolizumab pegol ( CZP ) 200 mg every two week placebo . The primary objective demonstrate efficacy CZP patient .</brief_summary>
	<brief_title>Multicenter Study Evaluating Certolizumab Pegol Compared Placebo Subjects With axSpA Without X-ray Evidence AS</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Spondylarthritis</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>At least 18 year old start Screening Visit A documented diagnosis adultonset axial SpondyloArthritis ( axSpA ) define specify Assessment SpondyloArthritis International Society ( ASAS ) criteria least 12 month symptom duration screen No sacroiliitis define Modified New York ( mNY ) criterion sacroiliac ( SI ) xrays Active disease Screening define Bath Ankylosing Spondylitis Disease Activity Index ( BASDAI ) score ≥ 4 Spinal pain ≥ 4 0 10 Numerical Rating Scale ( NRS ) Inadequate response , contraindication , intolerant least 2 Nonsteroidal AntiInflammatory Drugs ( NSAIDs ) Diagnosis Inflammatory Arthritis Prior treatment experimental biological agent treatment Axial SpondyloArthritis ( SpA ) Exposure 1 TNFantagonist primary failure TNF antagonist therapy History current chronic recurrent infection High risk infection Recent live vaccination Concurrent malignancy history malignancy Class III IV congestive heart failure New York Heart Association ( NYHA ) Demyelinating disease central nervous system Female subject breastfeeding , pregnant plan become pregnant study within 3 month follow last dose investigational product Subjects condition , investigator 's judgment , would make subject unsuitable inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Axial Spondyloarthritis</keyword>
	<keyword>axSpA</keyword>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>Anti TNF-alpha</keyword>
	<keyword>Certolizumab Pegol</keyword>
	<keyword>Nr-axSpA</keyword>
	<keyword>Non-radiographic</keyword>
	<keyword>Spondylarthropathies</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Spinal Diseases</keyword>
	<keyword>Immunosuppressive Agents</keyword>
</DOC>